Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria.

Autor: van Leth F; 1 University of Amsterdam Amsterdam, the Netherlands.; 2 Amsterdam Institute for Global Health and Development Amsterdam, the Netherlands., Günther G; 3 Research Center Borstel Borstel, Germany.; 4 German Center for Infection Research (DZIF) Borstel, Germany.; 5 University of Namibia, School of Medicine Windhoek, Namibia., Hoffmann H; 6 SYNLAB Gauting, SYNLAB Humane Genetic Munich-Gauting, Germany.; 7 Institute of Microbiology & Laboratory Medicine, Dpt IML red; WHO Supranational Reference Laboratory of Tuberculosis Munich-Gauting, Germany., Lange C; 3 Research Center Borstel Borstel, Germany.; 4 German Center for Infection Research (DZIF) Borstel, Germany.; 8 University of Lübeck Lübeck, Germany and.; 9 Karolinska Institute Stockholm, Sweden.
Jazyk: angličtina
Zdroj: American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2017 Dec 01; Vol. 196 (11), pp. 1489-1490.
DOI: 10.1164/rccm.201705-0995LE
Databáze: MEDLINE